Real-Time Polymerase Chain Reaction (PCR) with Allelic Discrimination Analysis
This test is used for identifying patients who may require warfarin (Coumadin) dosing adjustments including: patients who are receiving warfarin for the first time; patients who have required multiple dosing adjustments to maintain the international normalized ratio (INR) in the target range; and patients with a history of thrombosis or bleeding when taking warfarin.
Interpretive report provided.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
3 - 12 days
- Warfarin Sensitivity Analysis
- Cytochrome P450 2C9 Genotyping
- Vitamin K Epoxide Reductase C1 Genotyping
- CYP450 Genotype
- VKORC1 Genotype
- CYP2C9 Genotype
Test sent to Mayo Medical Laboratories.